Best Medicine for Dementia: The Life-Long Defense of the Brain

Author:

Andersson Marcus J.1,Stone Jonathan2

Affiliation:

1. Faculty of Medicine and Health, University of Sydney, Camperdown, NSW, Australia

2. School of Medical Sciences and Faculty of Medicine and Health, University of Sydney, Camperdown, NSW, Australia

Abstract

This review deals with an unwelcome reality about several forms of dementia, including Alzheimer’s disease— that these dementias are caused, in part or whole, by the aging of the vasculature. Since the vasculature ages in us all, dementia is our fate, sealed by the realit!ies of the circulation; it is not a disease with a cure pending. Empirically, cognitive impairment before our 7th decade is uncommon and considered early, while a diagnosis in our 11th decade is late but common in that cohort (>40%). Projections from earlier ages suggest that the prevalence of dementia in people surviving into their 12th decade exceeds 80%. We address the question why so few of many interventions known to delay dementia are recognized as therapy; and we try to resolve this few-and-many paradox, identifying opportunities for better treatment, especially pre-diagnosis. The idea of dementia as a fate is resisted, we argue, because it negates the hope of a cure. But the price of that hope is lost opportunity. An approach more in line with the evidence, and more likely to limit suffering, is to understand the damage that accumulates with age in the cerebral vasculature and therefore in the brain, and which eventually gives rise to cognitive symptoms in late life, too often leading to dementia. We argue that hope should be redirected to delaying that damage and with it the onset of cognitive loss; and, for each individual, it should be redirected to a life-long defense of their brain.

Publisher

IOS Press

Subject

Psychiatry and Mental health,Geriatrics and Gerontology,Clinical Psychology,General Medicine,General Neuroscience

Reference128 articles.

1. The mechanical cause of age-related dementia (Alzheimer’s disease): The brain is destroyed by the pulse;Stone;J Alzheimers Dis,2015

2. Cerebral microvascular pathology is a common endophenotype between traumatic brain injury, cardiovascular disease, and dementia: A hypothesis and review;Swanson;Cureus,2022

3. The brain’s weakness in the face of trauma: How head trauma can cause the delayed destruction of the brain;Johnstone;Front Neurosci,2023

4. The neuropathology and cerebrovascular mechanisms of dementia;Raz;J Cereb Blood Flow Metab,2016

5. A review on cholinesterase inhibitors for Alzheimer’s disease;Anand;Arch Pharm Res,2013

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3